Albany, CA, United States of America

Sarah M McWhirter

USPTO Granted Patents = 3 

Average Co-Inventor Count = 8.8

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sarah M McWhirter

Introduction

Sarah M McWhirter is a prominent inventor based in Albany, California. She has made significant contributions to the field of immunology through her innovative inventions. With a total of 3 patents, her work focuses on activating immune responses using cyclic-di-nucleotide (CDN) immune stimulators.

Latest Patents

McWhirter's latest patents include compositions and methods for activating 'stimulator of interferon gene' (STING) dependent signaling. The first patent provides highly active CDN immune stimulators that activate dendritic cells (DCs) via the STING receptor. This invention emphasizes the use of cyclic purine dinucleotides that induce human STING-dependent type I interferon production. The second patent also centers on CDN immune stimulators, detailing compositions that include mono-fluoro and di-fluoro substituted mixed linkage CDNs.

Career Highlights

Throughout her career, McWhirter has worked with notable companies such as Chinook Therapeutics, Inc. and Aduro Biotech Inc. Her expertise in immunology and innovative approaches have positioned her as a key figure in her field.

Collaborations

Some of her notable coworkers include George Edwin Katibah and David Braun Kanne. Their collaborative efforts have contributed to advancing research in immune signaling and therapeutic applications.

Conclusion

Sarah M McWhirter's contributions to immunology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in immune therapies and treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…